Prendio is a Life Science eProcurement company founded in 2015 and headquartered in the United States. The company offers a trusted eProcurement software as a service (SaaS) solution tailored for the biotechnology and pharmaceutical industries. Prendio's solution aims to accelerate research and development in the life science space by providing scalable, intuitive procurement technology. By leveraging industry expertise, the company implements purpose-built software to simplify internal workflows, resulting in an organized system of controls and streamlined procurement and A/P processes. The recent Private Equity Round investment on 18 October 2023 was led by Primus Capital, a significant indicator of investor confidence in Prendio's potential. With its industry expertise, specialized software capabilities, technical support, and a focus on simplified workflows, Prendio empowers life science organizations and their partners to optimize project funding and achieve transformational outcomes.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Private Equity Round | Unknown | 1 | Primus Capital Partners | 18 Oct 2023 |
No recent news or press coverage available for Prendio.